Actual U.S. Corporate Tax Rates Are in Line with Comparable Countries
End Notes
[1] This paper primarily relies on Treasury Office of Tax Analysis (OTA) estimates in “The Case for Responsible Business Tax Reform,” January 2017, http://bit.ly/2p1Jkff, unless otherwise noted. Effective tax rate for Pfizer was estimated by Americans for Tax Fairness using the company’s Securities and Exchange Commission filings. For further discussion and comparison of estimates, see Laura Power, “The Devil is in the Details: A Comparison of the Corporate Average Effective Tax Rate Calculations Used by Government Agencies,” Office of Tax Analysis Working Paper 105, January 2016, http://bit.ly/2zdyohF and Jane G. Gravelle, “International Corporate Tax Rate Comparisons and Policy Implications,” CRS, January 6, 2014, http://bit.ly/2lRe15u.
[2] See CBPP, “Corporate Tax Cuts Mainly Benefit Shareholders and CEOs, Not Workers,” August 21, 2017, http://bit.ly/2erA9SP; CBPP, “Corporate Rate Cuts Are a Poor Way to Help the Economy and Most Workers — and Could Hurt Them,” updated June 9, 2017, http://bit.ly/2vXgX5V.